Phillip R Selby

8PUBLICATIONS
27CO-AUTHORS
Nanotoxicology, health and safetyMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 10, 2026
ANZTCT cytomegalovirus practice survey for allogeneic haemopoietic stem cell transplant and cellular therapy recipients in Australia and New Zealand.

|Sep 01, 2026
Infection risk in myelodysplastic syndromes is dynamic and immune driven.

|Apr 30, 2026
Evaluation of Current and Novel Dosing Strategies for Anti-Thymocyte Globulin in Adult Allogeneic Hematopoietic Stem Cell Transplantation.

|Jun 28, 2024
Determination of a vancomycin nephrotoxicity threshold and assessment of target attainment in hematology patients.

Sherilyn Wong, Philip R Selby, Stephanie E Reuter

|Jan 13, 2024
Population pharmacokinetics of posaconazole in allogeneic haematopoietic stem cell transplant patients.

Philip R Selby, Aaron J Heffernan, David Yeung

|Feb 23, 2023
Population Pharmacokinetics of Ganciclovir in Allogeneic Hematopoietic Stem Cell Transplant Patients.

Philip R Selby, Aaron J Heffernan, David Yeung

Pageof 2

Frequent Collaborators

2 joint publications

Aaron J Heffernan

2 joint publications

Jason A Roberts

2 joint publications

Stephanie E Reuter

1 joint publications

Sherilyn Wong